Christina Fournier is a Neurology physician affiliated with Emory University. OpenAlex indexes 75 publications with 2,480 citations (h-index 22); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1365 Clifton Rd NE
Atlanta, GA 303221013
Telephone
404-778-3444Registry record last updated 21 Jan 2014.
Clinical trials
- Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)
Sponsor: Emory University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Takeda Pharmaceuticals U.S.A., Inc.Program year202511 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
65.7%Benzothiazole22.3%Riluzole100%Part D≥20 patientsBenzodiazepine15.7%Clonazepam77%Diazepam23%Part D<11 patients+ 4 more classes in this area
Musculoskeletal
18%gamma-Aminobutyric Acid-ergic Agonist11.7%Baclofen100%Part D≥11 patientsCentral alpha-2 Adrenergic Agonist6.3%Tizanidine Hcl100%Part D<11 patientsRespiratory
8%Anticholinergic8%Glycopyrrolate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2017–2021 per NIH RePORTER. The latest:
- Novel Prediction Tools for Amyotrophic Lateral Sclerosis
Veterans Health Administration
FY2021IK2CX001595 - Novel Prediction Tools for Amyotrophic Lateral Sclerosis
Veterans Health Administration
FY2020IK2CX001595 - Novel Prediction Tools for Amyotrophic Lateral Sclerosis
Veterans Health Administration
FY2019IK2CX001595
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
James Lah, MD
Emory University
Keith Delman, MD
Emory University
John Puskas, MD
Emory University
Craig Hofmeister, MD
Emory University
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”